ProMetic’s Therapy Improved Fibrosis, Cardiac Function in Mice with Heart Failure
News, Pulmonary Hypertension
ProMetic Life Science’s fibrosis-targeting investigational drug PBI-4050 improved pulmonary hypertension (PH), lung remodeling and right ventricular function in mice with heart failure. PBI-4050 also decreased biomarkers for heart disease in patients with ... Read more